These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16573296)

  • 21. Antenatal steroids to prevent respiratory distress syndrome: multiple gestation as an effect modifier.
    Quist-Therson EC; Myhr TL; Ohlsson A
    Acta Obstet Gynecol Scand; 1999 May; 78(5):388-92. PubMed ID: 10326882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal respiratory distress syndrome as a function of gestational age and an assay for surfactant-to-albumin ratio.
    McElrath TF; Colon I; Hecht J; Tanasijevic MJ; Norwitz ER
    Obstet Gynecol; 2004 Mar; 103(3):463-8. PubMed ID: 14990407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The surfactant system protects both fetus and newborn.
    Hallman M
    Neonatology; 2013; 103(4):320-6. PubMed ID: 23736009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades?
    Mugford M
    Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
    Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early administration of surfactant in spontaneous breathing with nCPAP through a thin endotracheal catheter--an option in the treatment of RDS in ELBW infants?
    Kribs A
    J Perinatol; 2009 Mar; 29(3):256. PubMed ID: 19240733
    [No Abstract]   [Full Text] [Related]  

  • 27. [Programmed labor. Can RDS be prevented even after amniotomy? (author's transl)].
    Husslein P; Salzer H
    Z Geburtshilfe Perinatol; 1980 Apr; 184(2):123-7. PubMed ID: 6893885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a single dose of antenatal steroid in surfactant-treated babies under 31 weeks' gestation.
    Sen S; Reghu A; Ferguson SD
    J Matern Fetal Neonatal Med; 2002 Nov; 12(5):298-303. PubMed ID: 12607761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
    Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
    Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The status of prenatal lung ripening].
    Wolff F; Bolte A
    Geburtshilfe Frauenheilkd; 1990 Mar; 50(3):171-6. PubMed ID: 2187733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-/-) mouse pups.
    Cuevas Guaman M; Sbrana E; Shope C; Showalter L; Hu M; Meloche S; Aagaard K
    Pediatr Res; 2014 Jul; 76(1):24-32. PubMed ID: 24732107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis of neonatal respiratory distress syndrome by intra-amniotic administration of pulmonary surfactant.
    Zhang JP; Wang YL; Wang YH; Zhang R; Chen H; Su HB
    Chin Med J (Engl); 2004 Jan; 117(1):120-4. PubMed ID: 14733787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of respiratory distress syndrome: synergistic therapies.
    Gross I
    Mead Johnson Symp Perinat Dev Med; 1988; (33):37-41. PubMed ID: 2485442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period.
    Parmigiani S; Panza C; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current potentials for the antenatal prevention of the idiopathic respiratory distress syndrome].
    Marinov B; Ruseva R
    Akush Ginekol (Sofiia); 1983; 22(4):330-3. PubMed ID: 6322606
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of effects of endotracheal suction and surfactant administration on hemodynamics and oxygenation of premature infants--a near infrared spectroscopy study].
    Roll C; Horsch S; Knief J; Hüsing J; Hanssler L
    Z Geburtshilfe Neonatol; 2001; 205(3):104-9. PubMed ID: 11474988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of surfactant replacement trials.
    Suresh GK; Soll RF
    J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
    Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.